Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Consumer awareness and strategies among families with high-deductible health plans.
Cyclin-Dependent Kinase 6
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.
Student Health Services
Toxicity Tests
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectr. 2025 Jan 28.
View in:
PubMed
authors with profiles
Lawrence H. Kushi, ScD
Mai Nhu Nguyen-Huynh, MD, MAS
Marilyn L. Kwan, PhD